LNTH  valuation analysis

Basics
Name: Lantheus Holdings, Inc
Description: Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 25, 2021
Market cap: $1.43B (1159th)
Sales(TTM): $339.41M (1283rd)
Earnings(TTM): -$13.47M (1080th)

Value
FFER: 1.19 (why)
Actual price: $21.35
FFEThis is Lantheus Holdings, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $16.54
Quantile: LNTH is priced correctly given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Lantheus Holdings, Inc's earnings decreased from $52.88M to -$13.47M in the last year.
  • Lantheus Holdings, Inc's operating income decreased from $51.66M to -$4.20M in the last year.
Earnings / MarketCap
Lantheus Holdings, Inc
"Diagnostics & Research" industry
Sales / MarketCap
Lantheus Holdings, Inc
"Diagnostics & Research" industry
Book / MarketCap
Lantheus Holdings, Inc
"Diagnostics & Research" industry
Equity / Assets
Lantheus Holdings, Inc
"Diagnostics & Research" industry